High thrombin activatable fibrinolysis inhibitor levels are associated with an increased risk of premature peripheral arterial disease
Authors:
- Emile L.E. de BruijneEBEmile L.E. de Bruijne
- Ann GilsAGAnn Gils
- Dingeman C. RijkenDRDingeman C. Rijken
- Moniek P.M. de MaatMMMoniek P.M. de Maat
- Ana H.C. GuimarãesAGAna H.C. Guimarães
- Don PoldermansDPDon Poldermans
- Paul J. DeclerckPDPaul J. Declerck
- Frank W.G. LeebeekFLFrank W.G. Leebeek
- 1 March 2011
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 127 (3) , 254-258
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hypofibrinolysis is a risk factor for arterial thrombosis at young ageBritish Journal of Haematology, 2009
- Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in childrenJournal of Thrombosis and Haemostasis, 2008
- Ankle—brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohortVascular Medicine, 2007
- Fibrinolysis and the risk of venous and arterial thrombosisCurrent Opinion in Hematology, 2007
- High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic strokeJournal of Thrombosis and Haemostasis, 2005
- TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME StudyJournal of Thrombosis and Haemostasis, 2005
- A new functional assay of thrombin activatable fibrinolysis inhibitorJournal of Thrombosis and Haemostasis, 2005
- Thrombophilic risk factors for symptomatic peripheral arterial diseaseJournal of Vascular Surgery, 2005
- Risk of Ischemic Stroke Associated With Functional Thrombin-Activatable Fibrinolysis Inhibitor Plasma LevelsStroke, 2003
- Thrombin-Activable Fibrinolysis Inhibitor Levels in the Acute Phase of Ischemic StrokeStroke, 2003